Express Scripts Holding Co. has named James Havel as its chief financial officer, the company said Tuesday. Havel, previously an executive vice president with the company, is replacing Eric Slusser, who is leaving to pursue other opportunities, the company said.
Also on Tuesday, the St. Louis County-based pharmacy benefit manager said net profit for the third quarter rose to $841.7 million, or $1.46 per share, from $722.9 million, or $1.15 per share, a year earlier. Excluding items, the company earned $1.90 per share, in line with analysts’ expectations.
Revenue for the period ended Sept. 30 fell about 3 percent to $24.68 billion, below the analyst average estimate of $25.64 billion.
Despite the increase in net income, Express Scripts dispensed fewer prescriptions during the third quarter, down 1 percent to 344 million adjusted claims.
Read more: St. Louis Post-Dispatch